Association between clinical characteristics and pain relief in patients with axial spondyloarthritis treated with non-steroidal anti-inflammatory drugs
The patients were divided into the relief group (≥30% improvement in NRS) and non-relief group (
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: The aim of this study was to evaluate pain relief in axial spondyloarthritis (axSpA) patients treated with non-steroidal anti-inflammatory drugs (NSAIDs) and to investigate the relation of the demographic, clinical, and psychological characteristics with pain relief.
📊
Key Findings & Data:Patients and methods: Between February 2017 and December 2019, a total of 94 patients (61 males, 33 females; mean age: 28.3±8.1 years; range, 14 to 54 years) who were diagnosed with axSpA and treated with NSAIDs were included.
💡
Conclusion & Impact:The patients were divided into the relief group (≥30% improvement in NRS) and non-relief group (
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters
Abstract
Objectives: The aim of this study was to evaluate pain relief in axial spondyloarthritis (axSpA) patients treated with non-steroidal anti-inflammatory drugs (NSAIDs) and to investigate the relation of the demographic, clinical, and psychological characteristics with pain relief. Patients and methods: Between February 2017 and December 2019, a total of 94 patients (61 males, 33 females; mean age: 28.3±8.1 years; range, 14 to 54 years) who were diagnosed with axSpA and treated with NSAIDs were included. The patients were assessed at baseline and at three months. A reduction of 30% in the Numeric Rating Scale (NRS) indicates a clinically meaningful improvement. The patients were divided into the relief group (≥30% improvement in NRS) and non-relief group (
🔖
Cite This Article
SUN, E., HE, Y., DENG, S., DENG, S., LI, L. (2022). Association between clinical characteristics and pain relief in patients with axial spondyloarthritis treated with non-steroidal anti-inflammatory drugs. Archives of Rheumatology, Cilt: 37 - Sayı: 2, 271–279. https://ajindex.com/articles/447968
Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet 2017;390:73-84
Bagcivan G, Cinar FI, Cinar M, Oflaz F, Uzun S, Pay S. Living with pain in ankylosing spondylitis: A qualitative study. Contemp Nurse 2015;51:135- 47
Bidad K, Gracey E, Hemington KS, Mapplebeck JCS, Davis KD, Inman RD. Pain in ankylosing spondylitis: A neuro-immune collaboration. Nat Rev Rheumatol 2017;13:410-20
Durmus D, Sarisoy G, Alayli G, Kesmen H, Çetin E, Bilgici A, et al. Psychiatric symptoms in ankylosing spondylitis: Their relationship with disease activity, functional capacity, pain and fatigue. Compr Psychiatry 2015;62:170-7
Kwan YH, Fong W, Cheng GHL, Phang JK, Leung YY, Lui NL, et al. The mediating role of pain and function in the association between stiffness and quality of life in patients with axial spondyloarthritis. Semin Arthritis Rheum 2019;49:377-80
Heiberg T, Lie E, van der Heijde D, Kvien TK. Sleep problems are of higher priority for improvement for patients with ankylosing spondylitis than for patients with other inflammatory arthropathies. Ann Rheum Dis 2011;70:872-3
Kiltz U, Baraliakos X, Regel A, Bühring B, Braun J. Causes of pain in patients with axial spondyloarthritis. Clin Exp Rheumatol 2017;35 Suppl 107:102-7. 8. van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 2017;76:978-91
Poddubnyy D. Axial spondyloarthritis: Is there a treatment of choice? Ther Adv Musculoskelet Dis 2013;5:45-54
Toussirot E. Pharmacological management of axial spondyloarthritis in adults. Expert Opin Pharmacother 2019;20:1483-91
Swinnen TW, Westhovens R, Dankaerts W, de Vlam K. Widespread pain in axial spondyloarthritis: Clinical importance and gender differences. Arthritis Res Ther 2018;20:156
Ji Y, He Y, Nian X, Sun E, Li L. Inflammatory or Neuropathic Pain: Characteristics and their relationships with disease activity and functional status in axial spondyloarthritis patients. Pain Med 2019;20:882-8
Geler-Külcü D, Batıbay S, Öztürk G, Mesci N. The association of neuropathic pain and disease activity, functional level, and quality of life in patients with ankylosing spondylitis: A cross-sectional study. Turk J Med Sci 2018;48:257-65
Gok K, Cengiz G, Erol K, Ozgocmen S. Neuropathic pain component in axial spondyloarthritis and the influence on disease burden. J Clin Rheumatol 2018;24:324-7. 1